Results 61 to 70 of about 109,296 (278)

Re‐salvage focal low‐dose rate brachytherapy for local recurrence of prostate cancer after salvage focal low‐dose rate brachytherapy

IJU Case Reports
Introduction Salvage brachytherapy represents an effective treatment for local recurrence of prostate cancer after prior external beam radiotherapy. However, the optimal therapeutic strategies for local recurrence after salvage brachytherapy have not yet
Takahiro Nakamoto, Takashi Yoshida, Toshiko Shiga, Makoto Taguchi, Takao Mishima, Shigenari Kawakita, Takashi Murota, Hidefumi Kinoshita   +7 more
doaj   +1 more source

Combined CONVentional with HYPOfractionated regimen (CONV-HYPO) alternative instead of conventionally fractionated radiotherapy to improve treatment outcomes

Nowotwory
For years, the process of accelerated repopulation recognized as a dominant factor for radiotherapy failures has beendeduced rather than proved by direct clinical data. It sounds logical and that towards the end of fractionated radiotherapyresidual tumor
Bogusław Maciejewski, Małgorzata Kraszkiewicz, Piotr Wojcierszek, Jean-Pierre Gerard   +3 more
doaj   +1 more source

Focal Spot, Fall/Winter 1989 [PDF]

, 1989
https://digitalcommons.wustl.edu/focal_spot_archives/1053/thumbnail ...

core   +1 more source

Dosimetry characterization of $^{32}$P intravascular brachytherapy source wires using Monte Carlo codes PENELOPE and GEANT4

, 2003
Monte Carlo calculations using the codes PENELOPE and GEANT4 have been performed to characterize the dosimetric parameters of the new 20 mm long catheter based $^{32}$P beta source manufactured by Guidant Corporation.
Agostinelli, Antonio M. Lallena, Asenjo, Bohm, Fox, Garcı́a-Toraño, Javier Torres, Julio F. Almansa, Li, Manuel J. Buades, Mourtada, Mourtada, Nath, Pocock, Pötter, Rafael Guerrero, Schaart, Sehgal, Sánchez-Reyes, Vynckier, Waksman, Wang   +21 more
core   +1 more source

Magnetic resonance imaging for localization of prostate cancer in the setting of biochemical recurrence [PDF]

, 2016
The clinical suspicion of local recurrence of prostate cancer after radical treatment is based on the onset of biochemical failure. The use of multiparametric magnetic resonance imaging (MRI) for prostate cancer has increased over recent years, mainly ...
Barchetti, Flavio, Cardone, Gianpiero, Catalano, Carlo, Colarieti, Anna, Grompone, Marcello Domenico, Panebianco, Valeria, Salvo, Vincenzo   +6 more
core   +1 more source

Focal therapy using a novel cooled laser device for prostate cancer: early trial results

BJU International, EarlyView.
Objectives To determine the short‐term oncological results and safety of the ProFocal Laser Therapy for Prostate Tissue Ablation (PFLT‐PC) trial, the first phase II clinical trial of ProFocal® (Medlogical Innovations, Sydney, Australia), a novel, cooled laser focal therapy (cLFT) device for prostate cancer (PCa) treatment. Patients and Methods Men with
Jonathan Kam, Bishoy Hanna, Stuart Jackson, Stephen McCombie, George McClintock, Matthew J. Roberts, Jake Rahkala, Jeremy Teoh, Mohan Arianayagam, Bertram Canagasingham, Ahmed Saeed Goolam, Nicola Jeffery, Matthew Winter, Mohamed Khadra, Raymond Ko, Nicholas Mehan, Isaac Thangasamy, Celi Varol   +17 more
wiley   +1 more source

Review of brachytherapy clinical trials: a cross-sectional analysis of ClinicalTrials.gov

Radiation Oncology
Introduction Characterizing the landscape of clinical trials including brachytherapy can provide an overview of the current status and research trends which may guide further areas of investigation.
David Chen, Rod Parsa, Kabir Chauhan, Jelena Lukovic, Kathy Han, Amandeep Taggar, Srinivas Raman   +6 more
doaj   +1 more source

The Australian Penile Cancer Clinical Registry: a comprehensive national approach to data collection

BJU International, EarlyView.
Background Penile cancer is a rare malignancy, with an Australian incidence of 0.6 in 100 000 men, with a wide range of clinical presentations, from localised, curable tumours to aggressive forms with high morbidity and mortality. Epidemiological data and management guidelines for penile cancer in Australia are limited.
Henry Y.C. Pan, David Homewood, Harrison Lucas, Brendan Dittmer, Jiasian Teh, Jonathan S. O'Brien, Jianliang Liu, Ben Tran, Justin Chee, James A. Churchill, Nathan Lawrentschuk, Niall M. Corcoran   +11 more
wiley   +1 more source

Is there a role for an external beam boost in cervical cancer radiotherapy?

Frontiers in Oncology, 2013
Objectives: Some patients are medically unfit for or averse to undergoing a brachytherapy boost as part of cervical cancer radiotherapy. In order to be able to definitively treat these patients, we assessed whether we could achieve a boost plan that ...
Rajni A. Sethi, Gabor eJozsef, David eGrew, Ariel eMarciscano, Ryan ePennell, Melissa eBabcock, Allison eMcCarthy, John eCurtin, Peter B. Schiff   +8 more
doaj   +1 more source

Improving plan quality and consistency by standardization of dose constraints in prostate cancer patients treated with CyberKnife. [PDF]

, 2013
Treatment plans for prostate cancer patients undergoing stereotactic body radiation therapy (SBRT) are often challenging due to the proximity of organs at risk.
Carrara, Mauro, Descovich, Martina, Gottschalk, Alexander R, Morlino, Sara, Nash, Marc B, Pignoli, Emanuele, Pinnaduwage, Dilini S, Pouliot, Jean, Roach, Mack, Saltiel, Daniel, Valdagni, Riccardo   +10 more
core   +2 more sources